Cellular reprogramming: a new approach to modelling Parkinson's disease.

Cellular reprogramming: a new approach to modelling Parkinson's disease.

iPSCs (induced pluripotent stem cells) offer an unparalleled opportunity to generate and study physiologically relevant cell types in culture. iPSCs can be generated by reprogramming almost any somatic cell type using pluripotency factors such as Oct4, SOX2, Nanog and Klf4. By reprogramming cells fr...

Полное описание

Библиографические подробности
Главные авторы:	Hartfield, E, Fernandes, H, Vowles, J, Cowley, S, Wade-Martins, R
Формат:	Journal article
Язык:	English
Опубликовано:	2012

Схожие документы

Physiological characterisation of human iPS-derived dopaminergic neurons
по: Hartfield, E, и др.
Опубликовано: (2014)

Physiological characterisation of human iPS-derived dopaminergic neurons
по: Hartfield, E, и др.
Опубликовано: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool.
по: Badger, J, и др.
Опубликовано: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool
по: Badger, J, и др.
Опубликовано: (2014)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
по: Zambon, F, и др.
Опубликовано: (2019)

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease
по: Keane, H, и др.
Опубликовано: (2015)

Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.
по: Vazquez-Arango, P, и др.
Опубликовано: (2016)

Physiological characterisation of human iPS-derived dopaminergic neurons.
по: Elizabeth M Hartfield, и др.
Опубликовано: (2014-01-01)

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
по: Sandor, C, и др.
Опубликовано: (2017)

Cell reprogramming therapy for Parkinson’s disease
по: Wenjing Dong, и др.
Опубликовано: (2024-01-01)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
по: Fernandes, H, и др.
Опубликовано: (2016)

Cellular reprogramming for understanding and treating human disease.
по: Riya Rajan Kanherkar, и др.
Опубликовано: (2014-11-01)

Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
по: Joo-Eun Lee, и др.
Опубликовано: (2020-08-01)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
по: Byounggook Cho, и др.
Опубликовано: (2024-11-01)

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
по: Yiming Wang, и др.
Опубликовано: (2023-08-01)

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
по: Fernandes, H, и др.
Опубликовано: (2017)

Are rodent models of Parkinson's disease behaving as they should?
по: Vingill, S, и др.
Опубликовано: (2017)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
по: Chao Zhou, и др.
Опубликовано: (2022-04-01)

Network pharmacology of the MPP+ cellular model of Parkinson’s disease
по: Keane, H
Опубликовано: (2015)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
по: Booth, H, и др.
Опубликовано: (2019)

Programming and reprogramming cellular identity
по: Marson, Alexander
Опубликовано: (2008)

Re: Epigenetics of Cellular Reprogramming
по: Fehmi Narter
Опубликовано: (2016-12-01)

Deterministic versus stochastic model of reprogramming: new evidence from cellular barcoding technique
по: Anastasia M. Yunusova, и др.
Опубликовано: (2017-01-01)

Convergent pathways in Parkinson’s disease
по: Cherubini, M, и др.
Опубликовано: (2017)

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair
по: Xingyu He, и др.
Опубликовано: (2022-12-01)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
по: Emma L Lane, и др.
Опубликовано: (2008-08-01)

Cellular Reprogramming toward the Erythroid Lineage
по: Laura J. Norton, и др.
Опубликовано: (2011-01-01)

Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes
по: Lang, C, и др.
Опубликовано: (2018)

Epigenetic reprogramming shapes the cellular landscape of schwannoma
по: S. John Liu, и др.
Опубликовано: (2024-01-01)

Epigenetic determinants of cellular differentiation, transcriptional reprogramming, and human disease
по: Nguyen, Khoi Thien.
Опубликовано: (2021)

The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
по: Bharathi Suresh, и др.
Опубликовано: (2016-01-01)

Dynamical systems theory of cellular reprogramming
по: Yuuki Matsushita, и др.
Опубликовано: (2022-04-01)

Cellular programming and reprogramming - Methods and protocols
по: CarloAlberto Redi
Опубликовано: (2010-12-01)

Implications of Cellular Aging in Cardiac Reprogramming
по: Fabiana Passaro, и др.
Опубликовано: (2018-04-01)

Neuroregeneration using in vivo cellular reprogramming
по: Tu Nguyen, и др.
Опубликовано: (2017-01-01)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
по: Booth, H, и др.
Опубликовано: (2017)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
по: Beevers, J, и др.
Опубликовано: (2013)

Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
по: J. Drouin-Ouellet, и др.
Опубликовано: (2012-01-01)

Exploring the Mitochondrial Degradome by the TAILS Proteomics Approach in a Cellular Model of Parkinson’s Disease
по: Marta Lualdi, и др.
Опубликовано: (2019-07-01)

New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
по: Sonia Lehri-Boufala, и др.
Опубликовано: (2015-01-01)